Nordic healthcare authorities want to negotiate shared deal over Bluebird Bio's gene therapy
Denmark, Sweden, Norway, Finland and Iceland will collectively negotiate with a pharmaceutical company over the price of a treatment for the first time.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.